SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-245615
Filing Date
2023-09-28
Accepted
2023-09-28 16:05:53
Documents
12
Period of Report
2023-09-27
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d558875d8k.htm   iXBRL 8-K 30421
  Complete submission text file 0001193125-23-245615.txt   148573

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nerv-20230927.xsd EX-101.SCH 2878
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE nerv-20230927_lab.xml EX-101.LAB 17236
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nerv-20230927_pre.xml EX-101.PRE 10831
6 EXTRACTED XBRL INSTANCE DOCUMENT d558875d8k_htm.xml XML 3285
Mailing Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

IRS No.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36517 | Film No.: 231289523
SIC: 2834 Pharmaceutical Preparations